Background and Objectives Chronic obstructive pulmonary disease (COPD) affects over 250
million people globally, carrying a notable economic burden. This systematic literature …

Non-communicable diseases are now the number one cause of disabilities and loss of life
expectancy. Among them, chronic respiratory conditions constitute a major class. The …

Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and loss of lung function, and is currently the third largest cause of death in the …

Background The Continuing to Confront COPD International Patient Survey estimated the
prevalence and burden of COPD across 12 countries. Using data from this survey we …

Objectives To find the economic burden of COPD and to identify the key cost drivers in the
management of COPD patients across different European countries. Background COPD is a …

Background Reliable up-to-date estimates regarding the economic impact of chronic
obstructive pulmonary disease (COPD) are lacking. This study investigates COPD excess …

Abstract Background Chronic Obstructive Pulmonary Disease (COPD) influences different
aspects of patient's health-related quality of life (HRQL). While disease-specific HRQL …

More than 50 causes of pleural effusion (PE) are recognized. 1 An estimated 1.5 million
patients in the US experience PE each year, with most cases caused by congestive heart …

Objective Younger persons with COPD report worse health-related quality of life (HRQL)
than do older individuals. The factors explaining these differences remain unclear. The …

Аннотация Целью данного исследования явилась оценка экономического ущерба от
болезней органов дыхания (БОД) и хронической обструктивной болезни легких …